Keyword Suggestion
Domain Informations
Abcellera.com lookup results from whois.godaddy.com server:
- Domain created: 2012-10-19T19:31:37Z
- Domain updated: 2024-10-15T18:11:04Z
- Domain expires: 2025-10-19T19:31:37Z 0 Years, 299 Days left
- Website age: 12 Years, 65 Days
- Registrar Domain ID: 1753364070_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS-1281.AWSDNS-32.ORG
- NS-1669.AWSDNS-16.CO.UK
- NS-3.AWSDNS-00.COM
- NS-972.AWSDNS-57.NET
Network
- inetnum : 208.113.128.0 - 208.113.255.255
- name : DREAMHOST-BLK6
- handle : NET-208-113-128-0-1
- status : Direct Allocation
- created : 2001-04-17
- changed : 2024-11-25
- desc : Address location was created regardless of geographic location.
Owner
- organization : New Dream Network, LLC
- handle : NDN
- address : Array,Brea,CA,92821,US
Abuse
- handle : DAT5-ARIN
- name : DreamHost Abuse Team
- phone : +1-714-706-4182
- email : [email protected]
Technical support
- handle : NETOP274-ARIN
- name : NetOPs
- phone : +1-714-706-4182
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 208.113.236.164
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Timezone: America/Los_Angeles
Site Inspections
Port Scanner (IP: 208.113.236.164)
Spam Check (IP: 208.113.236.164)
Email address with abcellera.com
2. [email protected]
3. [email protected]
4. [email protected]
Recent Searched Sites
› Blogvallenato.com (17 seconds ago) / US
› Impactlawar.com (6 seconds ago) / US
› X.ac (3 seconds ago) / US
› Abcdisposal.net (16 seconds ago) / US
› Fhamortgageweb.com (16 seconds ago) / US
› 121.241.45.21 (16 seconds ago) / IN
› Nuevodia.com.ve (11 seconds ago) / US
› Gulyasfa.hu (1 mins ago) / HU
› Vennea.com (0 seconds ago) / US
› Naturaco.beedoo.io (37 seconds ago) / US
› Zwartecross.nl (3 seconds ago) / US
› Serie-turche.com (1 mins ago) / US
› Paperlike.net (18 seconds ago) / CN
› Tuxedogov.org (2 seconds ago) / US
› Abcellera.com (0 seconds ago) / US
› Haweliamsterdam.com (39 seconds ago) / FI
› Chinajade.cn (16 seconds ago) / CN
› Tsainisfashion.gr (23 seconds ago) / GR
› Longviewnissan.com (35 seconds ago) /
› Abcdent.fr (28 seconds ago) / FR
Websites Listing
We found Websites Listing below when search with abcellera.com on Search Engine
AbCellera Biologics Inc. - Contact - Email Alerts
Subscribe To Investor Email Alerts. To receive notifications via email, enter your email address and select at least one subscription below. You can sign up for additional subscriptions at any time. By providing your email address below, you are providing consent to AbCellera Biologics Inc. to send you the requested Investor Email Alert updates.
Investors.abcellera.comAbCellera, Author at Life Sciences British Columbia
2021-11-24 · Email [email protected]; Address 2215 Yukon Street Vancouver, BC V5Y 0A1; Leadership Contact Carl Hansen, Director & CEO ; Follow us: Twitter; LinkedIn; Instagram; News; Jobs; November 24, 2021. Visionary Biotech Player Carl Hansen of AbCellera Named Canada’s EY Entrepreneur Of The Year® 2021. November 2, 2021 . Lilly to Supply 614,000 Additional …
Lifesciencesbc.caCarl Hansen | UBC's Michael Smith Laboratories
Email: [email protected]; website: https://www.abcellera.com; Departments. Michael Smith Laboratories; Research Area. Our group conducts cross-disciplinary research aimed at the development and application of microfluidic technology for basic and applied biomedical research. The overarching theme of our research is the development of technologies for single-cell …
Msl.ubc.caAbCellera Biologics Inc. - AbCellera to Report Full Year ...
2022-01-27 · AbCellera (Nasdaq: ABCL) announced today that it will report full year 2021 financial results after market close on Thursday, February 24, 2022 and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. The live webcast of the earnings conference will be available through a link that will be posted on …
Investors.abcellera.comAbCellera Email Formats & Employee Phones — Biotechnology ...
Contact and general information about AbCellera company, headquarter location in Vancouver, British Columbia. Email formats & phone numbers of …
Signalhire.comPrivacy Policy - AbCellera
ABCELLERA will not collect any individually identifiable information about you such as your name, address or email address unless you provide it to us voluntarily. If you do not want your individually identifiable information collected, please do not submit it to us. If you have already submitted this information and would like us to remove it ...
Abcellera.comAbCellera Biologics Inc. - AbCellera Announces the ...
2021-12-02 · AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, announced today the appointment of Neil Aubuchon as Chief Commercial Officer (CCO). Mr. Aubuchon brings over 20 years of experience in strategic planning, operations, and leadership for global biopharmaceutical companies, …
Investors.abcellera.comAbCellera Biologics Inc. (ABCL) Stock Price, News, Quote ...
AbCellera Biologics Inc. (NASDAQ: ABCL)Q4 2021 Earnings CallFeb 24, 2022, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, thank you for standing by, and welcome to the AbCellera full year 2021 earnings results and business update. Business Wire • 27 days ago.
Ca.finance.yahoo.comMidday Report: AbCellera (ABCL) Trades Higher March 30 ...
2022-03-30 · AbCellera Biologics Inc (NASDAQ: ABCL) has gained $0.36 (3.68%) and is currently sitting at $10.19, as of 11:45:36 est on March 30. 639,584 shares have traded hands. The Company has
Equities.comCareer openings at AbCellera
Career openings at AbCellera Current openings. Contact us. Do you dream big and want to make an impact? Work with us. We're expanding! Show All Openings. View position. Departments. Business Administration; Bioinformatics & Data Visualization; Molecular Biology & NGS; Cell Biology & Immunology; High-Throughput Screening ; Big Data & Machine Learning; CMC …
Abcellera.comAbcellera Biologics Inc (ABCL-Q) Quote - The Globe and Mail
AbCellera closes record biotech IPO as underwriters exercise option to buy shares; total proceeds US$555.5-million December 16, 2020 A Canadian biotech giant is born: AbCellera stock triples in ...
Theglobeandmail.comWorking at AbCellera - Glassdoor
I got an email after a few days and was notified that they decided not to move forward with my application. No feedback or explanation were given. I am not trying to cast a negative image on AbCellera via this review. Maybe it is a great company to work for. And, just like other people have mentioned, I also enjoyed the positive vibe and thought the people were very friendly, but …
Glassdoor.caAbCellera hiring Screening Instrumentation Technician in ...
At AbCellera, we find the next generation of therapeutic antibodies. To succeed, we have created innovative solutions at every step - custom antigen preparation and immunizations, microfluidics, high-throughput imaging, genomics, computation, machine learning and laboratory automation - leaving no stone unturned and revolutionizing how scientists can explore natural antibody …
Ca.linkedin.comAbCellera Reports Full Year 2021 Business Results, Total ...
2022-03-01 · AbCellera Reports Full Year 2021 Business Results, Total Revenue of US $375 Million (Up From $233M in 2020), and Liquidity of Over $720M. Vancouver, BC, March 1, 2022--AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, announced financial results for full year 2021. All financial …
Bctechnology.comB.C.'s AbCellera pushing feds, province for 'patent-box ...
2021-12-14 · B.C.'s AbCellera pushing feds, province for 'patent-box' tax breaks for IP-heavy companies . Author of the article: The Logic . Aleksandra Sagan . Publishing date: Dec 14, 2021 • December 14 ...
Montrealgazette.comVancouver-based AbCellera develops another COVID-19 ...
2022-02-20 · A local biotech company has discovered another antibody that will soon be used to treat COVID-19 patients. AbCellera, based in Vancouver, developed bebtelovimab, an antibody that prevents further ...
Bc.ctvnews.caAbcellera Biologics Inc (ABCL-Q) Press Releases - The ...
AbCellera (Nasdaq: ABCL) today announced Eli Lilly and Company (Lilly) has entered into a purchase agreement with the U.S. government to supply up …
Theglobeandmail.comAbcellera Biologics Inc (ABCL-Q) Quote - Press Release ...
AbCellera is building a technology company that drives innovation in antibody therapeutics which currently represents an estimated $170 billion market …
Theglobeandmail.comAbCellera-Discovered Antibody, Bebtelovimab, Receives U.S ...
2022-02-11 · AbCellera initially mobilized its pandemic response platform against COVID-19 in February of 2020, resulting in the discovery of bamlanivimab, the first monoclonal antibody therapy for COVID-19 to reach human testing and to be authorized for emergency use by the U.S. FDA. Bamlanivimab alone and together with other antibodies has treated at least 700,000 …
Financialpost.comSecurities Registration: Employee Benefit Plan (s-8)
2022-02-25 · The information contained in the Registrant’s registration statement filed on Form S-8 on December 15, 2020 (File No. 333-251341) is hereby incorporated by reference pursuant to General Instruction E. Proposed sales to take place as soon after the effective date of the Registration Statement as awards are granted, exercised or distributed ...
Ih.advfn.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| awoolner.com | namesilo.com | 6 Years, 64 Days |
| ajnnan.com | godaddy.com | -2 Years, -209 Days |
| oceanmicroendodontics.com | godaddy.com | -1 Years, -338 Days |
| maverickinspections.com | godaddy.com | 1 Year, 26 Days |
| bellevilleareaindependent.com | tucows.com | 1 Year, 30 Days |
| dolpxy.com | turhost.com | -2 Years, -109 Days |
| unitedplastics.com | networksolutions.com | 2 Years, 54 Days |
| penrosebrewing.com | godaddy.com | -2 Years, -23 Days |
| eduislam.in | godaddy.com | -2 Years, -272 Days |
| buzzmedia.net | tucows.com | -2 Years, -173 Days |